The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.
Open accessAbstract
Capsule formation plays a significant role in the pathogenicity of Cryptococcus neoformans. To study the molecular basis of capsule synthesis, the capsule-deficient phenotype of a mutant strain was complemented by transformation. A plasmid rescued from the resulting Cap+ transformant complemented a cap59 mutation which was mapped previously by classical recombination analysis. Gene deletion by homologous integration resulted in an acapsular phenotype, indicating that we have identified the CAP59 gene. The CAP59 gene was assigned to chromosome I by Southern blot analysis of contour-clamped homogeneous electric field gel electrophoresis-resolved chromosomes of C. neoformans var. neoformans. Sequence comparison of genomic and cDNA clones indicated the presence of six introns. CAP59 encoded a 1.9-kb transcript and a deduced protein of 458 amino acids. Analysis of the nucleotide sequence revealed little similarity to existing sequences in the data bank. When the capsule-deficient phenotype was complemented, the originally avirulent C. neoformans strain became virulent for mice. In addition, the acapsular strain created by gene deletion of CAP59 lost its virulence. This work demonstrates the molecular basis for capsule-related virulence and that the CAP59 gene is required for capsule formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA
Toffaletti, D. L., Rude, T. H., Johnston, S. A., Durack, D. T., & Perfect, J. R. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.5.1405-1411.1993 · Cited by 488
Genetic association of mating types and virulence in Cryptococcus neoformans
Kwon-Chung, K. J., Edman, J. C., & Wickes, B. L. (1992) · Infection and Immunity · doi:10.1128/iai.60.2.602-605.1992 · Cited by 434
Self-citationMorphogenesis of Filobasidiella neoformans, the Sexual State of Cryptococcus neoformans
Kwon-Chung, K. J. (1976) · Mycologia · doi:10.2307/3758800 · Cited by 352
Self-citationEncapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans
Kwon-Chung, K. J., & Rhodes, J. C. (1986) · Infection and Immunity · doi:10.1128/iai.51.1.218-223.1986 · Cited by 341
Self-citationVirulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.
Granger, D. L., Perfect, J. R., & Durack, D. T. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112000 · Cited by 319
Decreased virulence in stable, acapsular mutants ofCryptococcus neoformans
Fromtling, R. A., Shadomy, H. J., & Jacobson, E. S. (1982) · Mycopathologia · doi:10.1007/bf00636177 · Cited by 202
Edman, J. C., & Kwon-Chung, K. J. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4538 · Cited by 196
Self-citationCapsular Polysaccharides of Cryptococcus neoformans
Bhattacharjee, A. K., Bennett, J. E., & Glaudemans, C. P. J. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.5.619 · Cited by 192
Cited by
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
Mitchell, T. G., & Perfect, J. R. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.515 · Cited by 1,213
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis
Kwon-Chung, K. J., Fraser, J. A., Doering, T. L., Wang, Z. A., Janbon, G., Idnurm, A., & Bahn, Y.-S. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019760 · Cited by 531
Self-citationUrease as a Virulence Factor in Experimental Cryptococcosis
Cox, G. M., Mukherjee, J., Cole, G. T., Casadevall, A., & Perfect, J. R. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.443-448.2000 · Cited by 522
Calcineurin is required for virulence of Cryptococcus neoformans
Odom, A., Muir, S., Lim, E., Toffaletti, D. L., Perfect, J., & Heitman, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2576 · Cited by 516
Antifungal agents: chemotherapeutic targets and immunologic strategies
Georgopapadakou, N. H., & Walsh, T. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.279 · Cited by 498
Rodrigues, M. L., Nimrichter, L., Oliveira, D. L., Frases, S., Miranda, K., Zaragoza, O., Alvarez, M., Nakouzi, A., Feldmesser, M., & Casadevall, A. (2007) · Eukaryotic Cell · doi:10.1128/ec.00318-06 · Cited by 491
Sionov, E., Lee, H., Chang, Y. C., & Kwon-Chung, K. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000848 · Cited by 479
Self-citationHost‐Pathogen Interactions: The Attributes of Virulence
Casadevall, A., & Pirofski, L. (2001) · The Journal of Infectious Diseases · doi:10.1086/322044 · Cited by 463
Chapter 4 The Capsule of the Fungal Pathogen Cryptococcus neoformans
Zaragoza, O., Rodrigues, M. L., De Jesus, M., Frases, S., Dadachova, E., & Casadevall, A. (2009) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(09)01204-0 · Cited by 457
Cryptococcus neoformans mating and virulence are regulated by the G-protein α subunit GPA1 and cAMP
Alspaugh, J. A., Perfect, J. R., & Heitman, J. (1997) · Genes & Development · doi:10.1101/gad.11.23.3206 · Cited by 400
Chayakulkeeree, M., & Perfect, J. R. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.07.001 · Cited by 378
Groll, A. H., Piscitelli, S. C., & Walsh, T. J. (1998) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60129-5 · Cited by 377
The Cryptococcus neoformans Capsule: a Sword and a Shield
O'Meara, T. R., & Alspaugh, J. A. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-12 · Cited by 364
Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans
Cox, G. M., McDade, H. C., Chen, S. C. A., Tucker, S. C., Gottfredsson, M., Wright, L. C., Sorrell, T. C., Leidich, S. D., Casadevall, A., Ghannoum, M. A., et al. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02236.x · Cited by 362
Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis
Mylonakis, E., Ausubel, F. M., Perfect, J. R., Heitman, J., & Calderwood, S. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232568599 · Cited by 329
What Makes Cryptococcus neoformans a Pathogen?
Buchanan, K. L., & Murphy, J. W. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0401.980109 · Cited by 325
Conserved cAMP signaling cascades regulate fungal development and virulence
D’Souza, C. A., & Heitman, J. (2001) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(01)00058-4 · Cited by 325
D'Souza, C. A., Alspaugh, J. A., Yue, C., Harashima, T., Cox, G. M., Perfect, J. R., & Heitman, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3179-3191.2001 · Cited by 318
Gene disruption with PCR products in Saccharomyces cerevisiae
Lorenz, M. C., Muir, R. S., Lim, E., McElver, J., Weber, S. C., & Heitman, J. (1995) · Gene · doi:10.1016/0378-1119(95)00144-u · Cited by 286
Chang, Y. C., Stins, M. F., McCaffery, M. J., Miller, G. F., Pare, D. R., Dam, T., Paul-Satyasee, M., Kim, K. S., & Kwon-Chung, K. J. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.4985-4995.2004 · Cited by 278
Self-citationVirulence factors of medically important fungi
Hogan, L. H., Klein, B. S., & Levitz, S. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.469 · Cited by 271
Karkowska-Kuleta, J., Rapala-Kozik, M., & Kozik, A. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2452 · Cited by 253
Basic principles of the virulence of Cryptococcus
Zaragoza, O. (2019) · Virulence · doi:10.1080/21505594.2019.1614383 · Cited by 249
Cell wall α‐1,3‐glucan is required to anchor the Cryptococcus neoformans capsule
Reese, A. J., & Doering, T. L. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03780.x · Cited by 232
Cryptococcal Interactions with the Host Immune System
Voelz, K., & May, R. C. (2010) · Eukaryotic Cell · doi:10.1128/ec.00039-10 · Cited by 202
Chen, S. H. M., Stins, M. F., Huang, S.-H., Chen, Y. H., Kwon-Chung, K. J., Chang, Y., Kim, K. S., Suzuki, K., & Jong, A. Y. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05230-0 · Cited by 189
Self-citationLaccase of Cryptococcus neoformans Is a Cell Wall-Associated Virulence Factor
Zhu, X., Gibbons, J., Garcia-Rivera, J., Casadevall, A., & Williamson, P. R. (2001) · Infection and Immunity · doi:10.1128/iai.69.9.5589-5596.2001 · Cited by 188
Loss of cell wall alpha(1‐3) glucan affects Cryptococcus neoformans from ultrastructure to virulence
Reese, A. J., Yoneda, A., Breger, J. A., Beauvais, A., Liu, H., Griffith, C. L., Bose, I., Kim, M., Skau, C., Yang, S., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05551.x · Cited by 183
“We therefore generated an acapsular version of our serotype D ags1D mutant by crossing it to the acapsular strain B4131, which has a point mutation in the CAP59 gene (Chang and KwonChung, 1994).”
BackgroundMethodInfluentialBojarczuk, A., Miller, K. A., Hotham, R., Lewis, A., Ogryzko, N. V., Kamuyango, A. A., Frost, H., Gibson, R. H., Stillman, E., May, R. C., et al. (2016) · Scientific Reports · doi:10.1038/srep21489 · Cited by 170
Cruz, M. C., Fox, D. S., & Heitman, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.5.1020 · Cited by 150
Virulence-Associated Enzymes of Cryptococcus neoformans
Almeida, F., Wolf, J. M., & Casadevall, A. (2015) · Eukaryotic Cell · doi:10.1128/ec.00103-15 · Cited by 141
Rocha, J. D. B., Nascimento, M. T. C., Decote-Ricardo, D., Côrte-Real, S., Morrot, A., Heise, N., Nunes, M. P., Previato, J. O., Mendonça-Previato, L., DosReis, G. A., et al. (2015) · Scientific Reports · doi:10.1038/srep08008 · Cited by 136
Jong, A., Wu, C.-H., Chen, H.-M., Luo, F., Kwon-Chung, K. J., Chang, Y. C., LaMunyon, C. W., Plaas, A., & Huang, S.-H. (2007) · Eukaryotic Cell · doi:10.1128/ec.00120-07 · Cited by 113
Self-citationGilbert, N. M., Donlin, M. J., Gerik, K. J., Specht, C. A., Djordjevic, J. T., Wilson, C. F., Sorrell, T. C., & Lodge, J. K. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07119.x · Cited by 113
Jong, A., Wu, C.-H., Shackleford, G. M., Kwon-Chung, K. J., Chang, Y. C., Chen, H.-M., Ouyang, Y., & Huang, S.-H. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01128.x · Cited by 112
“Cryptococcus neoformans is encompassed by its capsule polysaccharide, which is a well-known major virulent factor in this yeast (Chang and Kwon-Chung, 1994; McFadden et al., 2006; Yauch et al., 2006).”
BackgroundSelf-citationNoverr, M. C., Williamson, P. R., Fajardo, R. S., & Huffnagle, G. B. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1693-1699.2004 · Cited by 112
Shen, W.-C., Davidson, R. C., Cox, G. M., & Heitman, J. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.3.366-377.2002 · Cited by 97
Jong, A., Wu, C.-H., Gonzales-Gomez, I., Kwon-Chung, K. J., Chang, Y. C., Tseng, H.-K., Cho, W.-L., & Huang, S.-H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353375 · Cited by 100
Self-citationThe role of the cell wall in fungal pathogenesis
Arana, D. M., Prieto, D., Román, E., Nombela, C., Alonso‐Monge, R., & Pla, J. (2009) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2008.00070.x · Cited by 92
Cryptococcus neoformans Histone Acetyltransferase Gcn5 Regulates Fungal Adaptation to the Host
O'Meara, T. R., Hay, C., Price, M. S., Giles, S., & Alspaugh, J. A. (2010) · Eukaryotic Cell · doi:10.1128/ec.00098-10 · Cited by 88
Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans
Huang, W., Liao, G., Baker, G. M., Wang, Y., Lau, R., Paderu, P., Perlin, D. S., & Xue, C. (2016) · mBio · doi:10.1128/mbio.00478-16 · Cited by 88
Recruitment of CD63 to Cryptococcus neoformans phagosomes requires acidification
Artavanis-Tsakonas, K., Love, J. C., Ploegh, H. L., & Vyas, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607528103 · Cited by 63
Petter, R., Kang, B. S., Boekhout, T., Davis, B. J., & Kwon-Chung, K. J. (2001) · Microbiology · doi:10.1099/00221287-147-8-2029 · Cited by 58
Self-citationStie, J., & Fox, D. (2012) · Microbiology · doi:10.1099/mic.0.051524-0 · Cited by 55
Emerging themes in cryptococcal capsule synthesis
Kumar, P., Yang, M., Haynes, B. C., Skowyra, M. L., & Doering, T. L. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.08.006 · Cited by 44
Barbosa, F. M., Fonseca, F. L., Figueiredo, R. T., Bozza, M. T., Casadevall, A., Nimrichter, L., & Rodrigues, M. L. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00296-06 · Cited by 33
“GXM is a virulence factor (4) that represents a potential vaccine component and is the target of therapeutic antibodies (3, 11, 17, 19).”
BackgroundStie, J., & Fox, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049402 · Cited by 12
Metadata
- Authors
- Chang, Y. C., & Kwon-Chung, K. J.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1994-07
- Volume
- 14
- Issue
- 7
- Pages
- 4912-4919
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2096855445
- Cited by
- 490
- References
- 24
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.